Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Ophthalmol Retina. 2018 Mar 21;2(9):963–971. doi: 10.1016/j.oret.2018.02.001

Figure 5.

Figure 5

Representative OCT B-scan and en face images of the temporal retina in a preterm infant with zone I stage 3 ROP, prior to (A) and three weeks after (B) intravitreal bevacizumab injection, showing regression of preretinal neovascular elevations and further vascularization of the previously avascular retina compared to images in (A).